Showing results (51-60 of 117) with videos related to
Sort By:
Pageof 12
Cancers|February 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous SystemJulia Wendler, Benjamin Kasenda, Eliza M Lauer, et al.Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.Cancers|December 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS LymphomaLisa K Isbell, Annika Vreden, Gabriele Ihorst, et al.Onkologie|February 5, 2005
Meeting report: primary central nervous system lymphoma: standards of care and future perspectivesUlrich Herrlinger, Agnieszka Korfel, Holger Hebart, et al.BMC Cancer|April 22, 2016
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix)Elisabeth Schorb, Juergen Finke, Andrés J M Ferreri, et al.BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.Haematologica|November 13, 2012
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group projectJacoline E Bromberg, Jeanette K Doorduijn, Gerald Illerhaus, et al.Neuro-Oncology|June 26, 2008
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomasStuart A Grossman, Kathryn A Carson, Surasak Phuphanich, et al.Science Translational Medicine|January 13, 2012
Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopyOvidiu C Andronesi, Grace S Kim, Elizabeth Gerstner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasHoward A Fine, Patrick Y Wen, Elizabeth A Maher, et al.Pageof 12